Lusong Luo

Lusong Luo

Company: BeiGene

Job title: Senior Vice President, External Innovation


Targeting RAS Mutations & MAPK Pathway Aberrations via Vertical Combination 5:30 pm

Vertical combination represents a useful approach to target the MAPK pathway aberrations including RAS mutations The synergistic activity from inhibition of the different nodes of the MAPK pathway leads to more complete and sustained pathway inhibition Inhibition of multiple nodes of the pathway suppresses the feedback activation of upstream signalling and potentially delay the development…Read more

day: Day One Track I

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.